Issue 53, 2020

Biomimetic asymmetric reduction of benzoxazinones and quinoxalinones using ureas as transfer catalysts

Abstract

Using ureas as transfer catalysts through hydrogen bonding activation, biomimetic asymmetric reduction of benzoxazinones and quinoxalinones with chiral and regenerable NAD(P)H models was described, giving chiral dihydrobenzoxazinones and dihydroquinoxalinones with high yields and excellent enantioselectivities. A key dihydroquinoxalinone intermediate of a BRD4 inhibitor was synthesized using biomimetic asymmetric reduction.

Graphical abstract: Biomimetic asymmetric reduction of benzoxazinones and quinoxalinones using ureas as transfer catalysts

Supplementary files

Article information

Article type
Communication
Submitted
29 Apr 2020
Accepted
21 May 2020
First published
27 May 2020

Chem. Commun., 2020,56, 7309-7312

Biomimetic asymmetric reduction of benzoxazinones and quinoxalinones using ureas as transfer catalysts

Z. Zhao, X. Li, M. Chen, Z. K. Zhao and Y. Zhou, Chem. Commun., 2020, 56, 7309 DOI: 10.1039/D0CC03091K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements